Michael E. Kamarck is a director of Vaxcyte, Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Vaxcyte, Inc.
15 Jun 23
4
Passage BIO, Inc.
26 May 23
4
Passage BIO, Inc.
6 Jul 22
3
Passage BIO, Inc.
6 Jul 22
4
Vaxcyte, Inc.
3 Jun 22
4
Trillium Therapeutics Inc.
19 Nov 21
4
Vaxcyte, Inc.
29 Oct 21
3
Vaxcyte, Inc.
29 Oct 21
3
Trillium Therapeutics Inc.
4 Jan 21
3
Vir Biotechnology, Inc.
10 Oct 19
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
13 Jun 23 | PCVX Vaxcyte | Common Stock | Grant | Acquire A | No | No | 0 | 2,500 | 0.00 | 5,625 |
13 Jun 23 | PCVX Vaxcyte | Stock Option Common Stock | Grant | Acquire A | No | No | 53.08 | 15,000 | 796.20 k | 15,000 |
25 May 23 | PASG Passage Bio | Director Stock Option Common Stock | Grant | Acquire A | No | No | 1 | 21,567 | 21.57 k | 21,567 |